News|Articles|August 2, 2023
How Patient Centricity is a Business Imperative for Life Sciences Companies
Author(s)ZS Associates
Patient centricity is an imperative focus for the advancement of life sciences businesses, and Sharon Suchotliff from ZS delves into this topic by sharing her keen insights.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
3
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
4
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
5